Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Clinical trial NCT07284472 · RECRUITING
Trial details
- NCT number
- NCT07284472
- Sponsor
- Exciva GmbH
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2029-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.